AEGERA THERAPEUTICS

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

#People #Financial #Website #More

AEGERA THERAPEUTICS

Social Links:

Facebook

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

1997-01-01

Address:

Montréal, Quebec, Canada

Country:

Canada

Website Url:

http://www.aegera.com

Total Employee:

11+

Status:

Closed

Contact:

(514) 288-553

Total Funding:

35.63 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail IPv6 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging

Current Advisors List

joseph-regan_image

Joseph Regan Member of the Board of Directors @ Aegera Therapeutics
Board_member

Current Employees Featured

jacques-jolivet_image

Jacques Jolivet
Jacques Jolivet Senior Vice-President of Clinical Development @ Aegera Therapeutics
Senior Vice-President of Clinical Development

not_available_image

Michael Atkin
Michael Atkin Founder & CEO @ Aegera Therapeutics
Founder & CEO

Founder

not_available_image

Michael Atkin

Acquisitions List

Date	Company	Article	Price
2007-08-08	LymphoSign	LymphoSign acquired by Aegera Therapeutics	N/A

Investors List

business-development-bank-of-canada_image

Official Site Inspections

http://www.aegera.com

Host Informations
Whois Informations

Loading ...